Cohen says he looked at around two dozen companies since Acorda wound down. Oryon Cell Therapies, with its funding, data and ...
Quality Growth SHANGHAI, March 24, 2026 /PRNewswire/ -- On 24 March, 2026, Fosun Pharma (the company, stock code: 600196.SH; ...
BioArctic's AB (publ) (STOCKHOLM: BIOA B ) partner Eisai presented new data at the 2026 International Conference on Alzheimer's and ...
The FDA has approved Denali Therapeutics’ enzyme replacement therapy for a genetic lysosomal storage disease, breaking the ...
If Gov. Brian Kemp signs the bill into law, some major changes would be coming to Georgia's medical marijuana program.
THAT WOULD EXPAND THE TYPE OF MEDICAL MARIJUANA PRODUCTS -- SOLD AT 'DIS- PENSARIES.' IT REMOVES PROGRAM. WJCL 22 NEWS' GRACE ...
Detailed price information for Serina Therapeutics Inc (SER-A) from The Globe and Mail including charting and trades.
Astronomical spring began yesterday, but the actual change of season is more gradual, a halting and nonlinear progression.
1don MSN
Exclusive: Biotech group leases 105,000 square feet in S.F. as it plans to hire 300 scientists
A biomedical research nonprofit has leased 105,000 square feet in the last major new building of San Francisco's Mission Bay.
Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: ...
In the 11 years since Georgia’s medical marijuana program started, it has slowly stumbled forward, with patients restricted to low-potency oils. The Georgia General Assembly is on the verge of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results